Symposium

Symposium1「Current Trends and Issues of Drug Metabolism Researches in Pharmaceutical Companies: Inspire future studies in Academia and Industry to facilitate drug development」

Thu. Nov 12, 2015 9:30 AM - 12:00 PM Room A (5ＦＢｉｇＨａｌｌ)

Organizer:Kan Chiba (Graduate School of Pharmaceutical Sciences, Chiba University), Organizers・Chairs:Nobuaki Watanabe (Drug Metabolism & Pharmacokinetic Research Laboratories, DAIICHI SANKYO Co.,LTD.), Miki Nakajima (Faculty of Pharmaceutical Sciences, Kanazawa University)

+Add all to schedule

[SY-01-01] Corresponding changes in metabolic studies for structural alteration of drug candidates

^○Yoshiaki Shimada (Pharmacokinetics-pharmacodynamics Analysis & Pharmacokinetics Research Labs., Drug Discovery Research, Astellas Pharma Inc.)

[SY-01-02] Prediction of human metabolite from non-clinical metabolism studies: the difficulties and its solutions

^○Takushi Kanazu (Drug Metabolism & Pharmacokinetics, Research Laboratory for Development, SHIONOGI & Co.,Ltd.)

[SY-01-03] The impact of CYP2J2 on human intestinal metabolism: Prediction of Fg using recombinant CYP

^○Itaru Natsutani (Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co.,Ltd.)

[SY-01-04] Contribution of unusual CYP isoforms in the main metabolic pathway and unexpected drug-drug interaction: A case study of tofogliflozin

^○Toshito Nakagawa (Research Division, Chugai Pharmaceutical Co.,Ltd.)

[SY-01-05] Recent experience for rare drug metabolism in Daiichi Sankyo

^○Kouichi Nakamura (Drug Metabolism & Pharmacokinetics Research Laboratories R&D Division, Daiichi Sankyo Co.,Ltd.)

[SY-01-06] Technologies for metabolite identification to support the acceleration of drug development

^○Kaori Murakoshi (DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation)